What does NNTG mean in MEDICAL
The Nordic Neuroendocrine Tumor Group (NNTG) is an international research and clinical network of clinicians, researchers and specialists from the Nordic countries. It was founded in 2004 to increase awareness, promote collaboration and improve patient care for NETs. NNTG consists of five institutions located in Denmark, Finland, Norway, Sweden and Iceland.
NNTG meaning in Medical in Medical
NNTG mostly used in an acronym Medical in Category Medical that means Nordic Neuroendocrine Tumor Group
Shorthand: NNTG,
Full Form: Nordic Neuroendocrine Tumor Group
For more information of "Nordic Neuroendocrine Tumor Group", see the section below.
Essential Questions and Answers on Nordic Neuroendocrine Tumor Group in "MEDICAL»MEDICAL"
What is NNTG?
The Nordic Neuroendocrine Tumor Group (NNTG) is an international research and clinical network of clinicians, researchers and specialists from the Nordic countries. It was founded in 2004 to increase awareness, promote collaboration and improve patient care for NETs.
What is the purpose of NNTG?
The primary aim of NNTG is to increase awareness, promote collaboration, and improve patient care for Neuroendocrine Tumors (NETs). This is achieved through various initiatives such as seminars, conferences, clinical trials and research projects.
How many institutions does the NNTG include?
The NNTG includes five institutions located in Denmark, Finland, Norway, Sweden and Iceland.
What types of initiatives does the NNTG carry out?
The NNTG carries out a variety of initiatives including seminars, conferences, clinical trials and research projects.
When was the NNGT founded?
The NNTG was founded in 2004.
Final Words:
The Nordic Neuroendocrine Tumor Group (NNTG) strives to advance the knowledge about NETs by increasing awareness among professionals that work with NETs through education initiatives as well as providing support for patients dealing with NETs. As a result of its collaborative efforts between its five Nordic member institutions it helps create better understanding about this rare type of cancer to lead to improved patient care.